This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Adverse effects and monitoring

Authoring team

  • methylphenidate may cause growth retardation and moderately reduced weight gain. May cause thrombocytopenia and leucopenia - periodic complete and differential blood and platelet counts are advised by the summary of product characteristics (SPC). Also the SPC recommends that blood pressure should be monitored

  • sleeplessness and nervousness are common side effects at the beginning of treatment with methylphenidate. These side effects can generally be controlled by dose adjustment (1)

The SPC should be consulted before prescribing this drug.

Reference:

  • (1) NICE (October 2000). Guidance on the Use of Methylphenidate (Ritalin, Equasym) for Attention Deficit / Hyperactivity Disorder (ADHD) in childhood.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.